ACADIA PHARMACEUTICALS INC

ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001070494

Price chart

Open-market purchases and sales by ACAD insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 7, 20266:00 PM ETAug 5 – Aug 6, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSSaleCommon Stock−20.14K$29.1565−$587.24K67.83K−22.9%SEC10b5-1
Jul 31, 20266:00 PM ETJul 30, 2026Thompson Elizabeth H.Z.EVP, Head of Research & DevSSaleCommon Stock−16.56K$26.1301−$432.66K18.99K−46.6%SEC
Jun 29, 2026Jun 26, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICERSSaleCommon Stock−11.42K$26.08−$297.86K13.09K−46.6%SEC10b5-1
May 27, 2026May 26, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICERSSaleCommon Stock−5.4K$21.18−$114.39K24.51K−18.1%SEC
May 5, 2026May 4, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSSaleCommon Stock−3.51K$21.79−$76.4K66.15K−5.0%SEC

The largest institutional positions in ACAD at the end of Q2 2026.

Institutions holding ACAD in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BAKER BROS. ADVISORS LP42,912,904$1.09B5.44%+16,2140.0%Added
BlackRock, Inc.22,515,173$569.63M0.01%+964,252+4.5%Added
STATE STREET CORP9,076,212$229.63M0.01%+743,441+8.9%Added
VANGUARD PORTFOLIO MANAGEMENT LLC8,838,450$223.61M0.01%+166,805+1.9%Added
RTW INVESTMENTS, LP7,144,524$180.76M1.54%00.0%Unchanged